• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The prevalence of tardive dyskinesia.

作者信息

Woerner M G, Kane J M, Lieberman J A, Alvir J, Bergmann K J, Borenstein M, Schooler N R, Mukherjee S, Rotrosen J, Rubinstein M

机构信息

Department of Psychiatry, Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, New York 11004.

出版信息

J Clin Psychopharmacol. 1991 Feb;11(1):34-42.

PMID:1674949
Abstract

A total of 2250 subjects from psychiatric and geriatric settings was examined for abnormal involuntary movements by the same team of trained raters employing a standard examination technique and rating scale. "Spontaneous" dyskinesia rates were 1.3% among 400 healthy elderly people surveyed at senior citizens centers, 4.8% among medical geriatric inpatients and ranged from 0 to 2% among psychiatric patients never exposed to neuroleptics. For samples of neuroleptic-treated patients, prevalence rates ranged from 13.3% among patients at a voluntary psychiatric hospital to 36.1% among state hospital patients. Logistic regression analyses revealed a large effect of age on tardive dyskinesia prevalence and an interaction of age with sex. Among younger subjects, men had higher rates; among subjects over age 40, rates were higher for women. Edentulousness and presence of other neurological disorders were possible contributors to high rates for the elderly. Even with control for age, sex and duration of neuroleptic exposure, prevalence differed markedly across study site.

摘要

相似文献

1
The prevalence of tardive dyskinesia.
J Clin Psychopharmacol. 1991 Feb;11(1):34-42.
2
The prevalence of akathisia in patients receiving stable doses of clozapine.接受稳定剂量氯氮平治疗的患者中静坐不能的患病率。
J Clin Psychiatry. 1994 Apr;55(4):142-5.
3
Prevalence of spontaneous dyskinesia in schizophrenia.精神分裂症患者中自发性运动障碍的患病率。
J Clin Psychiatry. 2000;61 Suppl 4:10-4.
4
Comparison of severe and mild tardive dyskinesia: implications for etiology.重度与轻度迟发性运动障碍的比较:对病因学的启示
J Clin Psychiatry. 1987 Sep;48(9):359-62.
5
Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.抗精神病药物所致运动障碍和帕金森症的预测因素:测量方法和定义的影响
J Clin Psychopharmacol. 2006 Dec;26(6):560-5. doi: 10.1097/01.jcp.0000245559.14284.e3.
6
The prevalence of persistent abnormal involuntary movements among patients in a Nigerian long stay psychiatric unit.尼日利亚一家长期住院精神科病房患者中持续性异常不自主运动的患病率。
Afr J Med Med Sci. 1981 Mar-Jun;10(1-2):39-43.
7
Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.成人使用非典型抗精神病药物时的迟发性运动障碍发生率:患病率和发病率。
J Clin Psychiatry. 2004;65 Suppl 9:16-20.
8
Prevalence of tardive dyskinesia.
J Clin Psychiatry. 1979 Dec;40(12):508-16.
9
Clinical and epidemiologic aspects of tardive dyskinesia.迟发性运动障碍的临床与流行病学特征
J Clin Psychiatry. 1985 Apr;46(4 Pt 2):8-13.
10
Tardive dyskinesia: prevalence, incidence, and risk factors.
J Clin Psychopharmacol. 1988 Aug;8(4 Suppl):52S-56S.

引用本文的文献

1
Predictors of extrapyramidal side effects among patients taking antipsychotic medication at Mekelle psychiatry units, Northern Ethiopia, 2023: unmatched case-control study.2023年埃塞俄比亚北部默克莱精神病科服用抗精神病药物患者锥体外系副作用的预测因素:非匹配病例对照研究
BMC Psychiatry. 2025 Aug 28;25(1):837. doi: 10.1186/s12888-025-07202-7.
2
Movement disorders of the mouth: a review of the common phenomenologies.口腔运动障碍:常见现象学综述。
J Neurol. 2022 Nov;269(11):5812-5830. doi: 10.1007/s00415-022-11299-1. Epub 2022 Jul 29.
3
5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia.
精神分裂症中的5-羟色胺受体与迟发性运动障碍
Front Mol Neurosci. 2020 Apr 24;13:63. doi: 10.3389/fnmol.2020.00063. eCollection 2020.
4
A defined human aging phenome.一个明确的人类衰老表型组。
Aging (Albany NY). 2019 Aug 12;11(15):5786-5806. doi: 10.18632/aging.102166.
5
Analysis of risk factors and outcomes in psychiatric inpatients with tardive dyskinesia: A nationwide case-control study.迟发性运动障碍精神科住院患者的危险因素及结局分析:一项全国性病例对照研究。
Heliyon. 2019 May 17;5(5):e01745. doi: 10.1016/j.heliyon.2019.e01745. eCollection 2019 May.
6
Treatment of neurolept-induced tardive dyskinesia.抗精神病药物所致迟发性运动障碍的治疗。
Neuropsychiatr Dis Treat. 2013;9:1371-80. doi: 10.2147/NDT.S30767. Epub 2013 Sep 16.
7
Bauhinia forficata prevents vacuous chewing movements induced by haloperidol in rats and has antioxidant potential in vitro.羊蹄甲可预防氟哌啶醇诱导的大鼠空嚼运动,并具有体外抗氧化潜力。
Neurochem Res. 2013 Apr;38(4):789-96. doi: 10.1007/s11064-013-0981-8. Epub 2013 Feb 2.
8
Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study.经四苯嗪、氯硝西泮和氯氮平联合治疗迟发性运动障碍的快速改善:一项自然长期随访研究。
J Neurol. 2012 Apr;259(4):660-4. doi: 10.1007/s00415-011-6235-2. Epub 2011 Nov 9.
9
Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.抗精神病药物引起的运动障碍:CATIE 精神分裂症试验的启示。
Neurol Clin. 2011 Feb;29(1):127-48, viii. doi: 10.1016/j.ncl.2010.10.002.
10
Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia.中国精神分裂症患者中迟发性运动障碍的患病率、风险及临床相关性的性别差异
Psychopharmacology (Berl). 2009 Sep;205(4):647-54. doi: 10.1007/s00213-009-1590-8. Epub 2009 Jun 16.